Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Sandra I. Coufal net worth and biography

Sandra Coufal Biography and Net Worth

Director of Tricida

Dr. Sandra I. Coufal, M.D., has served as a member of our board of directors since July 2013 and as a member of our Scientific Advisory Board since August 2013. Dr. Coufal is a co-founder and has served as a co-manager of Sibling Capital Ventures LLC, an affiliate of one of our principal stockholders, since 2013. Dr. Coufal was a co-founder and a co-manager of Sibling Capital, LLC from 2012 to 2016. For the past 17 years, Dr. Coufal has been the Biomedical Advisor for the Genomics Institute of the Novartis Research Foundation. Dr. Coufal served as the Head of the Division of Internal Medicine at the Torrey Pines site of Scripps Clinic from 1997 until 1999, was a member of the board of directors of Scripps Green Hospital from 1997 until 1999. Dr. Coufal founded and served on Relypsa, Inc.’s Scientific Advisory Board since 2007 and was a co-founder of Ilypsa’s Scientific Advisory Board. Dr. Coufal has served on the boards of directors of BioAesthetics Corporation and SafetySpot Inc., since February 2016 and March 2017, respectively. Dr. Coufal served as Associate Faculty in the Division of Internal Medicine for the University of California San Diego. She completed an internship and residency in Internal Medicine at the University of Texas Southwestern Medical School at Dallas. Dr. Coufal received her M.D. from the University of Texas Southwestern Medical School at Dallas and received her B.S. in Science Preprofessional Studies from the University of Notre Dame and was designated a Notre Dame Scholar.

What is Sandra I. Coufal's net worth?: The estimated net worth of Sandra I. Coufal is at least $0.00 as of August 24th, 2021. Dr. Coufal owns 148,912 shares of Tricida stock worth more than $0 as of April 23rd. This net worth approximation does not reflect any other assets that Dr. Coufal may own. Learn More about Sandra I. Coufal's net worth.
How do I contact Sandra I. Coufal?: The corporate mailing address for Dr. Coufal and other Tricida executives is 7000 SHORELINE COURT SUITE 201, SOUTH SAN FRANCISCO CA, 94080. Tricida can also be reached via phone at (415) 429-7800 and via email at [email protected]. Learn More on Sandra I. Coufal's contact information.
Has Sandra I. Coufal been buying or selling shares of Tricida?: Sandra I. Coufal has not been actively trading shares of Tricida within the last three months. Most recently, Sandra I. Coufal sold 7,500 shares of the business's stock in a transaction on Monday, December 20th. The shares were sold at an average price of $8.54, for a transaction totalling $64,050.00. Learn More on Sandra I. Coufal's trading history.
Who are Tricida's active insiders?: Tricida's insider roster includes Sandra Coufal (Director), and Gerrit Klaerner (CEO). Learn More on Tricida's active insiders.

Sandra I. Coufal Insider Trading History at Tricida

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/20/2021	Sell	7,500	$8.54	$64,050.00
12/15/2021	Sell	2,550	$8.01	$20,425.50
12/7/2021	Sell	15,722	$8.03	$126,247.66
12/1/2021	Sell	1,600	$8.02	$12,832.00
11/17/2021	Sell	10,297	$7.90	$81,346.30
10/6/2021	Sell	5,000	$4.22	$21,100.00
9/10/2021	Sell	5,000	$4.23	$21,150.00
8/24/2021	Sell	1,354	$4.01	$5,429.54	148,912
8/19/2021	Sell	3,100	$3.96	$12,276.00	150,812
7/20/2021	Sell	2,500	$4.02	$10,050.00	153,912
7/15/2021	Sell	2,500	$3.76	$9,400.00	156,412
6/8/2021	Sell	5,000	$4.78	$23,900.00	142,509
5/25/2021	Sell	5,000	$4.56	$22,800.00	147,509
4/19/2021	Sell	5,000	$4.54	$22,700.00	152,509
3/10/2021	Sell	5,000	$4.79	$23,950.00	157,509
2/3/2021	Sell	5,000	$6.91	$34,550.00	162,609
1/26/2021	Sell	5,000	$7.06	$35,300.00	167,609
12/14/2020	Sell	50,000	$7.90	$395,000.00	172,609
12/10/2019	Sell	713	$43.28	$30,858.64	216,939
11/22/2019	Sell	180,864	$41.00	$7,415,424.00	217,652
7/8/2019	Sell	2,000	$35.92	$71,840.00
2/28/2019	Sell	2,000	$23.04	$46,080.00
1/29/2019	Sell	1,972	$20.22	$39,873.84
7/2/2018	Buy	463,158	$19.00	$8,800,002.00

Sandra I. Coufal Buying and Selling Activity at Tricida

Tricida Company Overview

Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.

Today's Range

Now: N/A

50 Day Range

MA: $0.13

$0.11

$0.19

2 Week Range

Now: N/A

Volume

31,125,300 shs

Average Volume

17,618,414 shs

Market Capitalization

$6.01 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now